24H | Align, Tandem Diabetes Shares Soar 10% on Earnings Beat; Crypto Shares Rally With CleanSpark, Riot Platforms up 3%

Tiger Newspress
01 May

Align Technology shares rose more than 10% in overnight trading as it raised annual revenue growth forecast on Wednesday after beating quarterly results, driven by strong demand for its dental products.

The company now expects 2025 year-over-year revenue growth to be in the range of 3.5% to 5.5%, from previous low single-digit expectations.

Align makes teeth retainers, dental scanners and software for dental laboratories and practitioners. It produces some of its teeth aligners in Mexico and ships them to the United States. It also makes products in China for customers in that country.

Crypto shares rose in overnight trading as bitcoin rose above $95,000. TeraWulf up 5.8%; CleanSpark, Riot Platforms up 3%.

MGM Resorts International stock surged 3.3% in overnight trading following the release of its impressive first-quarter 2025 financial results and the announcement of a new share repurchase program. The casino and hospitality giant outperformed analysts' expectations, demonstrating resilience in its core business and success in the burgeoning online betting market.

Shares of Tandem Diabetes Care soared 10.21% in overnight trading, following the release of its first-quarter earnings report that showcased better-than-expected sales figures and reassuring forward guidance.

The medical device company, specializing in insulin delivery systems, reported Q1 sales of $234.42 million, significantly surpassing the analyst consensus estimate of $220.20 million. This represents a robust 22.3% increase compared to the same period last year. The company's worldwide sales growth was driven by a 22% increase in the United States and an impressive 35% growth outside the United States.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10